Some studies have shown that the expression of serum S100A9 is upregulated in some cancers, such as breast cancer and pancreatic cancer 11; many other studies have found significantly increased levels of serum S100A9 in inflammatory diseases, such as rheumatoid arthritis 22. This evidence concerns the gene S100A9 and pancreatic neoplasm.